Health Care/Hospital

AIA Singapore expands cross-border medical access and digitalised care for more than 1 million employees

 With over one-third (34%) of Singapore residents concerned over the affordability of healthcare services[1] and medical inflation projected to reach a record-high of 16.9%[2], AIA Singapore aims to bridge these cost and accessibility gaps with its upcoming corporate policy enhancements – all at ...

2026-07-30 11:00 435

Propel Health Australia Highlights Emerging Research into Fulvic Acid and Microplastics

BRISBANE, Australia, July 30, 2026 /PRNewswire/ -- Propel Health is highlighting new laboratory research published in Science of the Total Environment showing that fulvic acid can interact directly with microplastic particles under controlled conditions.

2026-07-30 08:01 307

Fosun International Issues Positive Profit Alert: Profit Attributable to Owners of the Parent for 1H2026 Expected to be Approx. RMB 1.5 Billion to RMB1.8 Billion

HONG KONG, July 29, 2026 /PRNewswire/ -- On 29th July, Fosun International (00656.HK) issued a positive profit alert. Its profit attributable to owners of the parent for the first half of 2026 is expected to range from approximately RMB1.5 billion to RMB1.8 billion representing an increase of app...

2026-07-29 17:35 1060

Ping An Ranks 48th on 2026 Fortune Global 500 List, Marking 17th Consecutive Year on List

HONG KONG and SHANGHAI, July 29, 2026 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An", the "Company" or the "Group"; HKEX: 2318; SSE: 601318) ranked No. 48 on the 2026 Fortune Global 500 list, released on July 28. The list ranks the world's largest corporations by reve...

2026-07-29 15:37 798

Wellness Culture Gains Momentum Across Asia Pacific as 4 in 5 Consumers Prioritize Holistic Health - Herbalife Survey

HONG KONG, July 29, 2026 /PRNewswire/ -- Herbalife, a premier health and wellness company, community and platform, released findings from its latest survey, revealing a clear rise in a wellness culture - the modern phenomenon that emphasizes the active pursuit of holistic well-being through the ...

2026-07-29 11:00 834

AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer

* ELAHERE is the first and only antibody-drug conjugate (ADC) therapy approved specifically for patients with folate receptor alpha (FRα) positive, platinum-resistant high grade serous epithelial ovarian cancer, fallopian tube or primary peritoneal cancer, who have received one to three prior s...

2026-07-29 10:00 828

Australian medtech Navi raises $A6.8 million to commercialise breakthrough paediatric technology in the US

MELBOURNE, Australia and BOSTON, July 29, 2026 /PRNewswire/ -- Melbourne- and Boston-based medical device company Navi Medical Technologies has closed a $A6.8 million capital raise to commercialise its breakthrough paediatric vascular access technology in the United States.

2026-07-29 08:00 981

Ozelle Launches O-Cyte 1 at ADLM 2026, Marking a New Step in AI-Powered Hematology

The global launch brings image-based morphology intelligence into routine hematology workflows through AI × CBM technology. FRANKFURT, Germany and ANAHEIM, Calif., July 29, 2026 /PRNewswire/ -- Ozelle has officially launched O-Cyte 1, its newest automated hematology a...

2026-07-29 05:00 792

IHH Healthcare Expands 'IHH Catalyst' to North Asia to Accelerate Clinical Adoption of Healthcare Innovation

Building on the success of its inaugural programme in India, IHH Healthcare is launching IHH Catalyst | North Asia Edition to help startups in Hong Kong, Chinese Mainland and neighbouring markets turn healthcare innovation into real-world clinical impact. HONG KONG and SINGAPORE and KUALA LUMPUR...

2026-07-28 18:44 576

Smartee Hosts Academic Programs in Thailand Highlighting Mandibular Repositioning Technology

BANGKOK, July 28, 2026 /PRNewswire/ -- Smartee Denti-Technology recently participated in two academic events in Bangkok, Thailand, focusing on the clinical principles and applications of its Mandibular Repositioning Technology. The programs brought together orthodontic professionals to exchange ...

2026-07-28 13:44 779

New report identifies opportunities to help more patients in Asia Pacific benefit from advances in AFib care

Growing physician confidence in pulsed field ablation highlights the need to strengthen referral pathways, education and healthcare system readiness SINGAPORE, July 28, 2026 /PRNewswire/ -- Boston Scientific today revealed findings from a new report showing that, while physicians in Asia Pacific ...

2026-07-28 11:00 849

The costly winter pet mistakes Australians are making

MELBOURNE, Australia, July 28, 2026 /PRNewswire/ -- As cost-of-living pressures bite, Petstock is warning pet parents not to overlook subtle winter health changes, which can lead to vet bills of up to $15,600 if left untreated.

2026-07-28 10:37 505

Everest Medicines Announces Participation in Upcoming Investor Conferences

SHANGHAI, July 27, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that Ian Woo, President and Chief Fi...

2026-07-27 23:17 855

TriNetX Appoints August Calhoun Chief Executive Officer

Jeff Margolis Resumes Chairman Role as Company Completes CEO Transition CAMBRIDGE, Mass., July 27, 2026 /PRNewswire/ -- TriNetX, The Global Truth Engine for Better Human Health™ and operator of the world's leading federated health data network, today announced the appointment ofAugust Calhoun as ...

2026-07-27 23:00 684

Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)

* STAgora™ analysis of approximately 60,000 test results collected over 42 months showed that STI pathogens were detected in 82% of HPV-positive cases * Findings support the potential value of a comprehensive testing approach that provides both HPV and STI pathogen information * Seegene to v...

2026-07-27 21:00 1312

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships

TAIPEI, July 27, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics,today reaffirmed its strategic focus on pursuing global li...

2026-07-27 20:20 863

Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer

* Brings Xevo™ TQ Absolute XR Mass Spectrometer's industry-leading tandem quadrupole MS sensitivity to clinical applications across women's health, cancer assessment, and toxicology. * Offers 5x greater sensitivity vs. in-class instruments with lower detection limits in smaller sample volum...

2026-07-27 20:10 933

Kelun-Biotech Receives a Clinical Trial Notice for Its First Dual-payload ADC SKB565

CHENGDU, China, July 27, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) today announced that it has received a clinical trial notice from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA)...

2026-07-27 19:40 591

Articura Launches a New Chapter for Sovereign Healthcare AI in Indonesia

Hospitals, clinics, academia and industry join a collaborative ecosystem designed to advance trusted, nationally grounded healthcare AI JAKARTA, Indonesia, July 27, 2026 /PRNewswire/ -- PT Articura Tech Indonesia ("Articura")today announced the foundation of its Sovereign Healthcare AI Platform,...

2026-07-27 19:02 1068

Ascletis Announces Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, Demonstrated Superior Weight Loss in a Diet-Induced Obese Mouse Model

-ASC37 demonstrated statistically significant 88% greater relative body weight reduction compared to tirzepatide in the diet-induced obese (DIO) mouse model. -Both ASC37 once-monthly subcutaneous (SQ) formulation and oral formulation will be submitted to the U.S. Food and Drug Administration (FDA...

2026-07-27 18:42 780
12345 ... 533